跳至主要内容
临床试验/CTRI/2023/12/060827
CTRI/2023/12/060827招募中不适用

Effectiveness of individualized homoeopathic medicines in the treatment of Acne vulgaris: Double- blind, randomized, placebo-controlled trial

Central council for research In Homoeopathy3 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2024年1月1日最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
120
试验地点
3
主要终点
Global Acne Grading Score (GAGS)

研究概览

简要总结

Title: "Effectiveness of Individualized Homoeopathic Medicines in the Treatment of Acne Vulgaris: A Double-Blind, Randomized, Placebo-Controlled Trial"

Abstract:

Objective: This double-blind, randomized, placebo-controlled trial aims to investigate the effectiveness of individualized homoeopathic medicines in the treatment of Acne Vulgaris.

Methods: A cohort of 120 individuals diagnosed with Acne Vulgaris will be randomly assigned to either the intervention group receiving individualized homoeopathic medicines or the control group receiving a placebo. The randomization will be performed using computer-generated random numbers. Both groups will be subjected to identical double-blind procedures, ensuring that neither the participants nor the investigators are aware of the treatment allocation.

Intervention: Participants in the intervention group will receive individualized homoeopathic medicines tailored to their specific symptoms and constitution. The selection of homoeopathic remedies will be based on a thorough individualized assessment conducted by experienced homoeopathic practitioners. The control group will receive a placebo with similar appearance and taste.

Outcome Measures: The primary outcome measure will be the reduction in GAGS score (Global Acne Grading system). Secondary outcome measures will include CADI score and photographic improvement.

Keywords: Acne Vulgaris, Homoeopathic Medicines, Individualized Treatment, Double-Blind, Randomized Controlled Trial, Placebo.

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Participant and Investigator Blinded

入排标准

年龄范围
11.00 Year(s) 至 40.00 Year(s)(—)
性别
All

入选标准

  • Patients willing to give written consent to undergo homoeopathic treatment.
  • Age range: 11-40 years.
  • Both sexes, all socio-economic status, all religions.
  • Those patients who have been diagnosed with acne vulgaris.
  • Patient willing to give written consent (Children between 11 to 15 years should give written consent in presence of parents).

排除标准

  • Patients suffering from life-threatening infections.
  • Cases already undergoing homoeopathic treatment elsewhere for other chronic disease.
  • Patients having Substance abuse and/ or dependence.
  • Patient below 11 years and above 40 years.
  • Patient suffering from other underlying deep dyscrasias like PCOS etc.
  • which is responsible for Acne vulgaris.

结局指标

主要结局

Global Acne Grading Score (GAGS)

时间窗: Fortnightly till 4month.

次要结局

  • Cardiff Acne disability index (CADI)(Fortnightly till 4month.)

研究者

发起方
Central council for research In Homoeopathy
申办方类型
Government funding agency

研究点 (3)

Loading locations...

相似试验